LXRX•benzinga•
Lexicon Pharmaceuticals (LXRX) Stock Is Down: What's Going On?
Summary
Lexicon Pharmaceuticals shares are trading lower by 48% Monday morning. The company earlier announced topline results from its PROGRESS Phase 2b study evaluating pilavapadin.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga